1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phage Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Phage Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Animal Health
1.3.3 Aquaculture
1.3.4 Agriculture
1.3.5 Food Industry
1.3.6 Human Health
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phage Therapy Market Perspective (2018-2029)
2.2 Phage Therapy Growth Trends by Region
2.2.1 Global Phage Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Phage Therapy Historic Market Size by Region (2018-2023)
2.2.3 Phage Therapy Forecasted Market Size by Region (2024-2029)
2.3 Phage Therapy Market Dynamics
2.3.1 Phage Therapy Industry Trends
2.3.2 Phage Therapy Market Drivers
2.3.3 Phage Therapy Market Challenges
2.3.4 Phage Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phage Therapy Players by Revenue
3.1.1 Global Top Phage Therapy Players by Revenue (2018-2023)
3.1.2 Global Phage Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phage Therapy Revenue
3.4 Global Phage Therapy Market Concentration Ratio
3.4.1 Global Phage Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phage Therapy Revenue in 2022
3.5 Phage Therapy Key Players Head office and Area Served
3.6 Key Players Phage Therapy Product Solution and Service
3.7 Date of Enter into Phage Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phage Therapy Breakdown Data by Type
4.1 Global Phage Therapy Historic Market Size by Type (2018-2023)
4.2 Global Phage Therapy Forecasted Market Size by Type (2024-2029)
5 Phage Therapy Breakdown Data by Application
5.1 Global Phage Therapy Historic Market Size by Application (2018-2023)
5.2 Global Phage Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Phage Therapy Market Size (2018-2029)
6.2 North America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Phage Therapy Market Size by Country (2018-2023)
6.4 North America Phage Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phage Therapy Market Size (2018-2029)
7.2 Europe Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Phage Therapy Market Size by Country (2018-2023)
7.4 Europe Phage Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phage Therapy Market Size (2018-2029)
8.2 Asia-Pacific Phage Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Phage Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Phage Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Phage Therapy Market Size (2018-2029)
9.2 Latin America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Phage Therapy Market Size by Country (2018-2023)
9.4 Latin America Phage Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phage Therapy Market Size (2018-2029)
10.2 Middle East & Africa Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Phage Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Phage Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NPO Microgen
11.1.1 NPO Microgen Company Detail
11.1.2 NPO Microgen Business Overview
11.1.3 NPO Microgen Phage Therapy Introduction
11.1.4 NPO Microgen Revenue in Phage Therapy Business (2018-2023)
11.1.5 NPO Microgen Recent Development
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Detail
11.2.2 Proteon Pharmaceuticals Business Overview
11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction
11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2018-2023)
11.2.5 Proteon Pharmaceuticals Recent Development
11.3 Phagelux
11.3.1 Phagelux Company Detail
11.3.2 Phagelux Business Overview
11.3.3 Phagelux Phage Therapy Introduction
11.3.4 Phagelux Revenue in Phage Therapy Business (2018-2023)
11.3.5 Phagelux Recent Development
11.4 Intralytix
11.4.1 Intralytix Company Detail
11.4.2 Intralytix Business Overview
11.4.3 Intralytix Phage Therapy Introduction
11.4.4 Intralytix Revenue in Phage Therapy Business (2018-2023)
11.4.5 Intralytix Recent Development
11.5 Micreos
11.5.1 Micreos Company Detail
11.5.2 Micreos Business Overview
11.5.3 Micreos Phage Therapy Introduction
11.5.4 Micreos Revenue in Phage Therapy Business (2018-2023)
11.5.5 Micreos Recent Development
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Detail
11.6.2 Eliava BioPreparations Business Overview
11.6.3 Eliava BioPreparations Phage Therapy Introduction
11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2018-2023)
11.6.5 Eliava BioPreparations Recent Development
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Detail
11.7.2 Locus Biosciences,Inc Business Overview
11.7.3 Locus Biosciences,Inc Phage Therapy Introduction
11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2018-2023)
11.7.5 Locus Biosciences,Inc Recent Development
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Detail
11.8.2 Pharmex Group,LLC Business Overview
11.8.3 Pharmex Group,LLC Phage Therapy Introduction
11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2018-2023)
11.8.5 Pharmex Group,LLC Recent Development
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Detail
11.9.2 Pherecydes Pharma Business Overview
11.9.3 Pherecydes Pharma Phage Therapy Introduction
11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2018-2023)
11.9.5 Pherecydes Pharma Recent Development
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Detail
11.10.2 APS Biocontrol Ltd. (APS) Business Overview
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction
11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2018-2023)
11.10.5 APS Biocontrol Ltd. (APS) Recent Development
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Detail
11.11.2 Qingdao Phagepharm Bio-tech Business Overview
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction
11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2018-2023)
11.11.5 Qingdao Phagepharm Bio-tech Recent Development
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Detail
11.12.2 Fixed-Phage Limited Business Overview
11.12.3 Fixed-Phage Limited Phage Therapy Introduction
11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2018-2023)
11.12.5 Fixed-Phage Limited Recent Development
11.13 Zeptometrix
11.13.1 Zeptometrix Company Detail
11.13.2 Zeptometrix Business Overview
11.13.3 Zeptometrix Phage Therapy Introduction
11.13.4 Zeptometrix Revenue in Phage Therapy Business (2018-2023)
11.13.5 Zeptometrix Recent Development
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Detail
11.14.2 Phage International, Inc. Business Overview
11.14.3 Phage International, Inc. Phage Therapy Introduction
11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2018-2023)
11.14.5 Phage International, Inc. Recent Development
11.15 MicroMir
11.15.1 MicroMir Company Detail
11.15.2 MicroMir Business Overview
11.15.3 MicroMir Phage Therapy Introduction
11.15.4 MicroMir Revenue in Phage Therapy Business (2018-2023)
11.15.5 MicroMir Recent Development
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Detail
11.16.2 iNtODEWORLD, Inc. Business Overview
11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction
11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2018-2023)
11.16.5 iNtODEWORLD, Inc. Recent Development
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Detail
11.17.2 NEXTBIOTICS Business Overview
11.17.3 NEXTBIOTICS Phage Therapy Introduction
11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2018-2023)
11.17.5 NEXTBIOTICS Recent Development
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Detail
11.18.2 Armata Pharmaceuticals, Inc. Business Overview
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction
11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2018-2023)
11.18.5 Armata Pharmaceuticals, Inc. Recent Development
11.19 Innophage
11.19.1 Innophage Company Detail
11.19.2 Innophage Business Overview
11.19.3 Innophage Phage Therapy Introduction
11.19.4 Innophage Revenue in Phage Therapy Business (2018-2023)
11.19.5 Innophage Recent Development
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Detail
11.20.2 Adaptive Phage Therapeutics Business Overview
11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction
11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2018-2023)
11.20.5 Adaptive Phage Therapeutics Recent Development
11.21 TechnoPhage
11.21.1 TechnoPhage Company Detail
11.21.2 TechnoPhage Business Overview
11.21.3 TechnoPhage Phage Therapy Introduction
11.21.4 TechnoPhage Revenue in Phage Therapy Business (2018-2023)
11.21.5 TechnoPhage Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
